Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

India's pharma giant Sun Pharma is to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted ...

Sun Pharmaceutical Industries Ltd. closed 17.87% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.94% to 1,581.95 Indian rupees Wednesday, on what proved to be an ...

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Sun Pharmaceuticals Industries Ltd is quoting at Rs 1673.25, up 1.08% on the day as on 12:49 IST on the NSE. The stock is up 7.36% in last one year as compared to a 1.54% jump in NIFTY and a 8.67% ...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, a company specialising in immunotherapy and ...

Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the ...

Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Checkpoint Therapeutics, Inc., a ...